Temporal multi-omics identifies LRG1 as a vascular niche instructor of metastasis. (2021)
Attributed to:
A Phase I/IIa Clinical Trial of a Humanised Monoclonal Antibody Against LRG1
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1126/scitranslmed.abe6805
PubMed Identifier: 34516824
Publication URI: http://europepmc.org/abstract/MED/34516824
Type: Journal Article/Review
Volume: 13
Parent Publication: Science translational medicine
Issue: 609
ISSN: 1946-6234